The RSV Vaccine Approved for Pregnant People 

The U.S. Food and Drug Administration (FDA) approved Abrysvo, a Respiratory Syncytial Virus (RSV) vaccine, the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth through 6 months of age. Abrysvo is approved for use at 32 through 36 weeks gestational age of pregnancy. Abrysvo is administered as a single-dose injection into the muscle. RSV is the leading cause of infant hospitalization in the U.S. The Prescribing Information for Abrysvo includes a warning to inform that a numerical imbalance in preterm births in Abrysvo recipients (5.7%) occurred compared to those who received a placebo (4.7%). The warning informs healthcare providers that to avoid the potential risk of preterm birth with the use of Abrysvo before 32 weeks of gestation, administer Abrysvo as indicated in pregnant individuals at 32 through 36 weeks of gestational age.

The post The RSV Vaccine Approved for Pregnant People  appeared first on Pennsylvania Office of Rural Health.

Recommend0 recommendationsPublished in My Healthy Pennsylvania, Rural Health PA

Related Articles

Protect Your Family from RSV

With the winter season in full swing, it’s peak time for flu, COVID-19, and RSV.   Respiratory syncytial virus (RSV) is a respiratory virus that usually causes mild, cold-like symptoms.  Most people recover in a week or two. But RSV can be serious, especially for infants and older adults. Latino children also face a “significantly higher burden.”  …
The post Protect Your Family from RSV appeared first on Salud America.

5 Essential Frameworks for Preventing Violent Child Death

The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.

FDA’s Big Plan to Enhance Public Health in 2025

The Food and Drug Administration (FDA) recently announced its request for $7.2 billion as part of President Joe Biden’s fiscal year (FY) 2025 proposed budget. FDA’s request, which is about 7% higher than last year, covers the agency’s top health priorities. “This funding will allow the agency to enhance food safety and nutrition, advance medical …
The post FDA’s Big Plan to Enhance Public Health in 2025 appeared first on Salud America.

The RSV Vaccine Approved for Pregnant People 

The U.S. Food and Drug Administration (FDA) approved Abrysvo, a Respiratory Syncytial Virus (RSV) vaccine, the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth through 6 months of age. Abrysvo is approved for use at 32 through 36 weeks gestational age of pregnancy. Abrysvo is administered as a single-dose injection into the muscle. RSV is the leading cause of infant hospitalization in the U.S. The Prescribing Information for Abrysvo includes a warning to inform that a numerical imbalance in preterm births in Abrysvo recipients (5.7%) occurred compared to those who received a placebo (4.7%). The warning informs healthcare providers that to avoid the potential risk of preterm birth with the use of Abrysvo before 32 weeks of gestation, administer Abrysvo as indicated in pregnant individuals at 32 through 36 weeks of gestational age.

The post The RSV Vaccine Approved for Pregnant People  appeared first on Pennsylvania Office of Rural Health.

Recommend0 recommendationsPublished in My Healthy Pennsylvania, Rural Health PA

Related Articles

Protect Your Family from RSV

With the winter season in full swing, it’s peak time for flu, COVID-19, and RSV.   Respiratory syncytial virus (RSV) is a respiratory virus that usually causes mild, cold-like symptoms.  Most people recover in a week or two. But RSV can be serious, especially for infants and older adults. Latino children also face a “significantly higher burden.”  …
The post Protect Your Family from RSV appeared first on Salud America.

5 Essential Frameworks for Preventing Violent Child Death

The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.

FDA’s Big Plan to Enhance Public Health in 2025

The Food and Drug Administration (FDA) recently announced its request for $7.2 billion as part of President Joe Biden’s fiscal year (FY) 2025 proposed budget. FDA’s request, which is about 7% higher than last year, covers the agency’s top health priorities. “This funding will allow the agency to enhance food safety and nutrition, advance medical …
The post FDA’s Big Plan to Enhance Public Health in 2025 appeared first on Salud America.